Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Analytical Chemistry

• Publication date

  2016-11-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/ACS.ANALCHEM.6B03437PMID 27804292PMCID PMC6512330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?

  2016cited by this paper
• Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.

  2016cited by this paper
• PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs.

  2016cited by this paper
• Immunogenicity of therapeutic recombinant immunotoxins

  2016cited by this paper
• Therapeutic Advances in Neurological Disorders

  2016cited by this paper
• Anti-PEG immunity: emergence, characteristics, and unaddressed questions.

  2015cited by this paper
• Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells.

  2015cited by this paper
• Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer

  2015cited by this paper
• Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

  2014cited by this paper
• Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

  2014cited by this paper
• IgG Subclasses and Allotypes: From Structure to Effector Functions

  2014cited by this paper
• Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins.

  2014cited by this paper
• Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial.

  2014cited by this paper
• The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.

  2013cited by this paper
• Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates

  2012cited by this paper
• Accelerated Blood Clearance of PEGylated PLGA Nanoparticles Following Repeated Injections: Effects of Polymer Dose, PEG Coating, and Encapsulated Anticancer Drug

  2012cited by this paper
• Stratification of Antibody-Positive Subjects by Antibody Level Reveals an Impact of Immunogenicity on Pharmacokinetics

  2012cited by this paper
• Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy

  2012cited by this paper
• Nanoparticle PEGylation for imaging and therapy.

  2011cited by this paper
• Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.

  2011cited by this paper
• 307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON

  2010cited by this paper
• The aging of the immune system

  2009cited by this paper
• Clinical immunotoxicity of therapeutic proteins

  2008cited by this paper
• Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

  2008cited by this paper
• Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patients

  2007cited by this paper
• Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.

  2006cited by this paper
• PEGylation, successful approach to drug delivery.

  2005cited by this paper
• Accelerated clearance of a second injection of PEGylated liposomes in mice.

  2003cited by this paper
• Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.

  2000cited by this paper
• A statistically defined endpoint titer determination method for immunoassays.

  1998cited by this paper
• A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats.

  1997cited by this paper
• Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion.

  1997cited by this paper
• Protein—surface interactions in the presence of polyethylene oxide

  1991cited by this paper
• Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors.

  1984cited by this paper
• Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins.

  1983cited by this paper
• Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens

  1981cited by this paper

• All-PEG-Like Block Copolymers Self-Assemble into Stealth Nanocarriers for Drug Delivery.

  2026cites this paper
• Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects

  2026cites this paper
• Poly(acrylamido) PEG-alternatives Enhance mRNA-LNP Efficacy in Immune Cells and Evade Anti-PEG Antibodies after Repeated Dosing

  2026cites this paper
• Engineered protein corona by Bispecific Antibody endows liposome with enhanced tumor targeting ability and mitigated accelerated blood clearance effect

  2026cites this paper
• DePEGylated liposomes incorporating novel amino acid lipids enable effective inhalation of asiatic acid for idiopathic pulmonary fibrosis treatment

  2026cites this paper
• Tuning the in vivo transfection efficiency of mRNA-Loaded lipoplexes by PEG-Lipid structure and ratio.

  2026cites this paper
• Clinical translation of injectable hydrogels: from bioactive polymers to long-acting drug delivery systems.

  2026cites this paper
• Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer.

  2026cites this paper
• Poly(sarcosine) Lipid Synthesis From CO2-Based Sarcosine-N-Carboxyanhydride.

  2026cites this paper
• Polyethylene glycol immunogenicity in nanomedicine

  2025influential citation
• Tuning the Functional Properties of Nanocarriers Using Tunable Nano‐Biointerfaces

  2025cites this paper
• Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

  2025cites this paper
• Development of Thermostable and Immunogenic Block Copolymer Nanoparticles (BNPs) for mRNA Delivery.

  2025cites this paper
• Sustainable Integration of Nanobiosensors in Biomedical and Civil Engineering: A Comprehensive Review

  2025cites this paper
• Beyond Conventional Approaches: The Revolutionary Role of Nanoparticles in Breast Cancer

  2025cites this paper
• Vehicles for antibiotic formulation in endodontic treatment: A narrative review

  2025cites this paper
• Long-acting lipid-based nanomedicines: rethinking from structure-based rational design to in vivo fate evaluation.

  2025cites this paper
• Efbemalenograstim Alfa, an Fc Fusion Protein, Long‑Acting Granulocyte Colony-Stimulating Factor for Reducing the Risk of Chemotherapy-Induced Neutropenia: Results of a Phase II Randomized, Multicenter, Open‑Label Trial

  2025cites this paper
• Detection of PEG-specific antibodies in SARS-CoV-2 positive and negative sera with implications for autoimmune reactivity

  2025influential citation
• Emerging lipid nanoparticle systems capable of efficient intramuscular RNA delivery.

  2025cites this paper
• Nanoparticle-Based Oral Insulin Delivery: Challenges, Advances, and Future Directions

  2025cites this paper
• Rapidly photocrosslinkable charged silk-based hydrogel for emergency hemostasis and multifunctional wound therapy

  2025cites this paper
• Development of a screening checklist to identify individuals with suspected allergy to polyethylene glycol

  2025cites this paper
• Polymerized stroma-free hemoglobin nanoparticle covalently coated with poly(2-ethyl-2-oxazoline) as a red blood cell substitute

  2025cites this paper
• Efbemalenograstim Alfa, a Long-Acting Granulocyte Colony-Stimulating Factor Fusion Protein Without PEGylation, Versus Pegfilgrastim for Management of Chemotherapy-Induced Neutropenia in Patients With Breast Cancer: Results of a Phase III Randomized Noninferiority Trial

  2025cites this paper
• Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform

  2025cites this paper
• Polymer Conjugation Benefits Proteins Beyond Simply Extended Half-life.

  2025cites this paper
• Balancing stealth and targeting to improve nanomedicine efficacy

  2025cites this paper
• "Actual" peptide properties required for nanoparticle development in precision cancer therapeutic delivery.

  2025cites this paper
• Poly(Oligo(Ethylene Glycol) Methacrylate)-Based Polymers in Biomedical Applications: Preparation and Applications.

  2025cites this paper
• Construction of Spleen-Accumulated Polysorbate 20-Containing Ionizable Lipid Nanoparticles for mRNA Delivery

  2025cites this paper
• Breaking the PEG barrier to boost mRNA-LNP therapeutics

  2025cites this paper
• Current Status and Future Prospects on Nanodelivery Systems Targeting the Small Intestine for Absorption of Bioactive Substances

  2025cites this paper
• Advances and Strategies in Enhancing mRNA Cancer Vaccines

  2025cites this paper
• The curious case of anti-PEG antibodies.

  2025cites this paper
• Anti-PEG Antibodies and Their Biological Impact on PEGylated Drugs: Challenges and Strategies for Optimization

  2025cites this paper
• Polyglycerol-Based Lipids: A Next-Generation Alternative to PEG in Lipid Nanoparticles for Advanced Drug Delivery Systems.

  2025cites this paper
• The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non‐Toxic Treatment Option for Superficial Triple Negative Breast Cancer

  2025cites this paper
• Biodegradable Polyglycerols Combining Antioxidant Activity and Sulfation-Induced Complement Inhibition

  2025cites this paper
• Plasma-Corona Signatures of PEG-Mimetic Exscalar Ultra-Stable AuNPs beyond Conventional Stability: A Proteomics Perspective

  2025cites this paper
• Polyphosphocholination of liposomic vehicles extends blood circulation, enhances cellular uptake, and lowers immunogenicity relative to PEGylation.

  2025cites this paper
• In vitro and in vivo correlation of injectable lipid-based nanomedicines: From dissolution to protein coronas

  2025cites this paper
• Overcoming the PEG dilemma with Poly(2-ethyl-2-oxazoline) lipids in lipid nanoparticle formulations

  2025cites this paper
• Propargylated cello-oligosaccharide nanosheets: a water-dispersible, antibiofouling, and post-functionalizable solid support for immunoassays.

  2025cites this paper
• Highly Tunable and Cell-Remodelable Thiol-ene Alginate-Peptide Crosslinked Hydrogels to Recreate Cellular and Organoid Microenvironments for Biofabrication.

  2025cites this paper
• Evaluating the Antiviral Efficacy of Encapsulated PKC Inhibitor BIM‐I against influenza A Virus Infection

  2025cites this paper
• Short-chain dense brush PEGylation on rigid nanocarriers overcomes anti-PEG antibody recognition for immune-stealth drug delivery.

  2025cites this paper
• Isomerization of Poly(ethylene glycol): A Strategy for the Evasion of Anti-PEG Antibody Recognition

  2025cites this paper
• Poly(sarcosine) and Poly(2-ethyl-2-oxazoline) Tethered To mRNA Provide Stealth Properties To mRNA Polyplexes

  2025cites this paper
• A Non-Antigenic Randomized Polyethylene Glycol/Poly(2-Phenyl-2-Oxazine)-Based Drug Delivery Platform.

  2025cites this paper
• Introducing Sulfur Ylides as Charge-Neutral Termini for Mitigating Poly(ethylene glycol) Antigenicity in Nanomedicine

  2025cites this paper
• Overcoming PEG Antigenicity: Statistical PEG Isomers Reduce Antibody Binding

  2025cites this paper
• Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics

  2025cites this paper
• Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity

  2025cites this paper
• Evaluation of Plasma Polyethylene Glycol (PEG) Levels in a Healthy Adult Population

  2025cites this paper
• Magnetic Nanoworm-Based Screening of Yeast Library for Anti-PEG Nanobodies.

  2025cites this paper
• Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum

  2024cites this paper
• Development of Hemoglobin Microbubbles for Acoustic Blood Oxygen Sensing: A Study on PEGylation and Gas Core Modification for In vivo Applications.

  2024cites this paper
• Impact of coverage and guest residue on polyproline II helix peptide antifouling

  2024cites this paper
• Polyethylene Glycols Stimulate Ca2+ Signaling, Cytokine Production, and the Formation of Neutrophil Extracellular Traps

  2024cites this paper
• Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review

  2024influential citation
• The Ambivalence of Post COVID-19 Vaccination Responses in Humans

  2024cites this paper
• Optimizing Pharmacological and Immunological Properties of Therapeutic Proteins Through PEGylation: Investigating Key Parameters and Their Impact

  2024influential citation
• Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts.

  2024cites this paper
• Anti-PEG antibodies associated with reduced therapeutic effect of patisiran in patients with hereditary transthyretin amyloidosis

  2024cites this paper
• Unlocking Trehalose's Versatility: A Comprehensive Journey from Biosynthesis to Therapeutic Applications.

  2024cites this paper
• Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies

  2024cites this paper
• Anaphylaxis after treatment with an endodontic material containing polyethylene glycol.

  2024cites this paper
• Polymer-mediated Protein/Peptide Therapeutic Stabilization: Current Progress and Future Directions

  2024cites this paper
• Surface modification of extracellular vesicles with polyoxazolines to enhance their plasma stability and tumor accumulation.

  2024cites this paper
• Virus-Mimetic Extracellular-Vesicle Vaccine Boosts Systemic and Mucosal Immunity via Immune Recruitment.

  2024cites this paper
• Exemplifying interspecies variation of liposome in vivo fate by the effects of anti-PEG antibodies

  2024cites this paper
• Mitigating the Effects of Persistent Antipolymer Immune Reactions in Nanomedicine: Evaluating Materials-Based Approaches Using Molecular Imaging.

  2024cites this paper
• Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles

  2024cites this paper
• Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions.

  2024cites this paper
• An Assay for Immunogenic Detection of Anti‐PEG Antibody

  2024cites this paper
• Vaccines and the Eye: Current Understanding of the Molecular and Immunological Effects of Vaccination on the Eye

  2024cites this paper
• Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin.

  2024cites this paper
• Biotin-Initiated Poly(oxazoline)s.

  2024cites this paper
• Reexamining in vivo fate of paclitaxel-loaded polymeric micelles

  2024cites this paper
• The effect of comb length on the in vitro and in vivo properties of self-assembled poly(oligoethylene glycol methacrylate)-based block copolymer nanoparticles.

  2024cites this paper
• Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles.

  2024cites this paper
• Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models

  2024cites this paper
• Effect of Poly(ethylene glycol) Configuration on Microbubble Pharmacokinetics.

  2024cites this paper
• Impact of PEG sensitization on the efficacy of PEG hydrogel-mediated tissue engineering

  2024cites this paper
• Study of uricase-polynorbornene conjugates derived from grafting-from ring-opening metathesis polymerization.

  2024cites this paper
• Determination of ω-end functionalities in tailored poly(2-alkyl-2-oxazoline)s by liquid chromatography and mass spectrometry

  2024cites this paper
• Research Progress on Injectable Microspheres as New Strategies for the Treatment of Osteoarthritis Through Promotion of Cartilage Repair

  2024cites this paper
• Anti-PEG antibodies: Current situation and countermeasures

  2024cites this paper
• Efbemalenograstim alfa not inferior to pegfilgrastim in providing neutrophil support in women with breast cancer undergoing myelotoxic chemotherapy: results of a phase 2 randomized, multicenter, open-label trial

  2024influential citation
• Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice.

  2024cites this paper
• Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in Swine.

  2024cites this paper
• Engineered extracellular vesicles as a next-generation vaccine platform

  2024cites this paper
• Circadian Rhythm-Dependent Therapy by Composite Targeted Polyphenol Nanoparticles for Myocardial Ischemia-Reperfusion Injury.

  2024cites this paper
• Engineering LNPs with polysarcosine lipids for mRNA delivery

  2024cites this paper
• Development of anti-PEG IgG/IgM/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergy.

  2024cites this paper
• Reciprocal Interaction with Neutrophils Facilitates Cutaneous Accumulation of Liposomes.

  2024cites this paper
• A singlicate immunogenicity method to detect anti-polyethylene glycol antibodies: pre- and post-dose of PEGylated therapies.

  2023cites this paper
• Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles

  2023cites this paper
• Unraveling the cytotoxicity and cellular uptake of low, medium and high molecular weight polyethylene glycol polymers in MCF-7 cells by green UPLC-MS/MS methods.

  2023cites this paper